维普中文期刊产品整合服务
106篇 您的检索式:作者名="Matulonis"
    题名 作者 年代 出处 被引量
1紫杉醇和多西紫杉醇超敏反应的快速脱敏疗法:一种成功应用于77例患者的新标准方案Feldweg A.M. Lee C.- W. Matulonis U.A. Castells M. 刘秀娟 2005世界核心医学期刊文摘(妇产科学分册)2005,0,7:2
2A pilot trial of TAC (paclitaxel,doxorubiein,and carboplatin)chemotherapy with filgastrim support followed by radiotherapy in patients with high-risk endometrial cancer显示文摘Duska LR Berkowitz R Matulonis U 2005Gynecol Oncol2005,96,:1
3A phase 11 trial of sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma 显示文摘CAMPOS S M PENSON R T MATULONIS U 2013Gynecol Oncol2013,128,2:1
4Phase II stud- y of carboplatin and pemetrexed for the treatment of platinum sensitive recurrent ovarian cancer 显示文摘Matulonis UA Horowitz NS Campos SM 2008J Clin Oncol2008,26,35:1
5A pilot trial of TAC (paclitaxe,doxorubicin,and carboplatin) chemotherapy with filgastrim support followed by radiotherapy in patients with high-risk endometrial cancer显示文摘Duska LR Berkowitz R Matulonis U 2005Gynecol Oncol2005,96,1:1
6Phase U study of carboplatin and pemetrexed for the treatment of plati- num- sensitive recurrent ovarian cancer显示文摘MATULONIS U A HOROWITZ N S CAMPOS S M 2008J Clin 0ncol2008,26,2:1
7A phase II trial of Suni- tinib malate in recurrent and refractory ovarian,fallopian tube and peritoneal carcinoma显示文摘Campos SM Penson RT Matulonis U 2012Gynecol Oncol2012,9,:1
8A phase Ⅱ trial of modified triple doublets for the treatment of advanced Müllerian malignancies显示文摘Matulonis UA Campos S Krasner C 2005Proc Am Soc Chin Oncol2005,23,:1
9Stereologic analysis of monocytes and their subcellular organelles in patients with acute monocytic and myelomonocytic leukemia 显示文摘Weiselberg L Matulonis U McGarvey E 1990Lab Invest1990,63,3:1
10Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fal- lopian tube,or primary peritoneal carcinoma 显示文摘Matulonis UA Sharma S Ghamande S 2012Gynecol Oncol2012,127,1:1
11Phase II study of bevacizumab in patients with platinum - resistant ovarian cancer or peritoneal serous caneer 显示文摘Cannistra SA Matulonis UA Penson RT 2007J Clin On- eol2007,25,33:1
12A phase II study of the MDR inhibitor biricodar (NCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy 显示文摘Seiden MV Swenerton KD Matulonis U 2002Gynecol Oncol2002,86,6:1
13A pilot trial of TAC ( paclitaxe, doxombicin, and carboplatin) chemo- therapy with filgastrim support followed by radiotherapy in patients with high - risk endometrial cancer 显示文摘Duska LR Berkowitz R Matulonis U 2005Gynecol Oncol2005,96,1:1
14Phase II, open-label, randomized, muhicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubiein in patients with BRCA1 or BRCA2 mutations and recurrent ovarian Cancer 显示文摘Kaye SB Lubinski J Matulonis U 2012Clin Oncol2012,30,4:1
15Phase II study ofbevacizumab in patients with platinum-resistant ovarian cancer orperitoneal serous cancer显示文摘Cannistra SA Matulonis UA Penson RT 2007J Clin Oncol2007,25,33:1
16Bevacizumab in patients with advanced platinum-resistant ovarian cancer显示文摘Cannistra SA Matulonis UA Penson R 2006J Clin Oncol2006,24,18:1
17Chemotherapy hypersensitivity reactions in ovarian cancer显示文摘Picard M Matulonis UA Castells M 2014J Natl Compr Canc Netw2014,12,3:1
18Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer 显示文摘Cannistra SA Matulonis UA Penson RT 2007J Clin Oncol2007,25,33:1
19A phase Ⅱ trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian,primaryperitoneal serous cancer,or fallopian tube cancer显示文摘Berkenblit A Seiden MV Matulonis UA 0,,03:1
20New advances in ovarian cancer显示文摘Liu J Matulonis UA 2010Oncology2010,24,8:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费